1. Home
  2. List
Reference Patent

Reference - List

  • 10 Hits
  • Search Condition : Filter (MeSH = Leukemia, Myeloid, Acute / drug therapy*)
Species Resource Title
Human and Animal Cells EoL-1 cell(RCB0641) p53 is critical for the Aurora B kinase inhibitor-mediated apoptosis in acute myelogenous leukemia cells.
Human and Animal Cells F-36P(RCB0775) Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines.
Human and Animal Cells 32Dcl3(RCB1377) Co-expression of wild-type FLT3 attenuates the inhibitory effect of FLT3 inhibitor on FLT3 mutated leukemia cells.
Human and Animal Cells RPMI8226(RCB3010) , KG-1(RCB1166) , MOLT-4(RCB0206) Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin.
Human and Animal Cells M-MOK(RCB2534) A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML.
Mice RBRC01361 Opposing effects of acute versus chronic inhibition of p53 on decitabine's efficacy in myeloid neoplasms.
Human and Animal Cells K562/Adr(RCB1898) Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation.
Human and Animal Cells 32D(RCB1145) Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia.
Human and Animal Cells K562(RCB1897) In vivo selective imaging and inhibition of leukemia stem-like cells using the fluorescent carbocyanine derivative, DiOC5(3).
Human and Animal Cells HNT-34(RCB1296) , U-937 DE-4(RCB0435) , K562(RCB0027) , KG-1(RCB1166) , HL60(RCB0041) , THP-1(RCB1189) CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression.